drugset / Trial / NCT04017247

Continuous Versus Intermittent Oxytocin Infusion for Induction of Labor

NCT04017247

Completed 153 enrolled Rambam Health Care Campus
RandomizedParallel-groupOpen-labelTreatment

Summary

The study will compare 2 treatment modalities. One group will receive the routine protocol of intermittent pitocin induction for 6 hours and the second group will receive continous pitocin infusion for 16 hours. The primary aim is to observe which protocol leads to the fastest delivery and evaluate the time in each group from induction to delivery.

Timeline

Start
2019-11-01
Primary completion
2022-06-30
Completion
2022-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 20 unknown

Indications

No indication recorded.